Inadequate anticoagulant treatment for stroke prevention in atrial fibrillation - PACE-CME

Inadequate anticoagulant treatment for stroke prevention in atrial fibrillation

Media formats available:

Ready to Claim Your Credits?

You have attempts to pass this post-test. Take your time and review carefully before submitting.

Good luck!

Recommended

Secondary prevention strategy led by nurses reduces MACE risk after an ACS
Secondary prevention strategy led by nurses reduces MACE risk after an ACS
ACC.25
Secondary prevention strategy led by nurses reduces MACE risk after an ACS
- Giulia Magnani, MD, PhD
AI model may accelerate risk stratification of coronary revascularization in ED
AI model may accelerate risk stratification of coronary revascularization in ED
ACC.25
AI model may accelerate risk stratification of coronary revascularization in ED
- Wayne Batchelor, MD
Ticagrelor antidote restores platelet function in phase 3 study
Ticagrelor antidote restores platelet function in phase 3 study
ACC.25
Ticagrelor antidote restores platelet function in phase 3 study
- Deepak Bhatt, MD
Trade off: Ischemic/Thrombotic vs Bleeding  
Trade off: Ischemic/Thrombotic vs Bleeding  
MinuteCE®
Trade off: Ischemic/Thrombotic vs Bleeding  
1.00 program credit
- Renato D. Lopes, MD, MHS, PhD
1.00 program credit